XML 64 R10.htm IDEA: XBRL DOCUMENT
v2.4.0.6

SHAREHOLDERS' EQUITY: | 3 Months Ended
--- | ---
Sep. 30, 2012
SHAREHOLDERS' EQUITY: |
SHAREHOLDERS' EQUITY: | 4. SHAREHOLDERS’ EQUITY: Net Income Per Share: The Company’s basic earnings per share is calculated as net income divided by weighted average common shares outstanding, excluding unvested outstanding RSAs and RSUs. The Company’s dilutive earnings per share is calculated as net income divided by weighted average common shares and common share equivalents outstanding, which includes shares issuable under the Company’s stock option plan and long-term incentive plan, and dilutive securities. Stock-based awards with exercise prices greater than the average market value of the Company’s common stock are excluded from the computation of diluted earnings per share. The Company’s dilutive earnings per share will also reflect the assumed conversion under the Company’s convertible debt if the impact is dilutive, along with the exclusion of interest expense, net of taxes. The impact of the convertible debt is excluded from the computation of diluted earnings per share when interest expense per common share obtainable upon conversion is greater than basic earnings per share. The following table sets forth a reconciliation of shares used in the computation of basic and diluted earnings per share:
|  | For the Three Months Ended September 30, |
|  | 2012 |  | 2011 |
|  | (Shares in thousands) |
Weighted average shares for basic earnings per share |  | 57,283 |  | 56,849 |
Effect of dilutive securities: |  |  |  |  |
Dilutive effect of stock-based compensation |  | 67 |  | 249 |
Dilutive effect of convertible debt |  | 11,239 |  | — |
Weighted average shares for diluted earnings per share |  | 68,589 |  | 57,098 |
The following table sets forth the awards which are excluded from the various earnings per share calculations:
|  | For the Three Months Ended September 30, |
|  | 2012 |  | 2011 |
|  | (Shares in thousands) |
Basic earnings per share: |  |  |  |  |
RSAs (1) |  | 501 |  | 858 |
RSUs (1) |  | 173 |  | 215 |
|  | 674 |  | 1,073 |
Diluted earnings per share: |  |  |  |  |
Stock options (2) |  | 585 |  | 826 |
SARs (2) |  | 444 |  | 1,030 |
RSAs (2) |  | — |  | 767 |
Shares issuable upon conversion of debt (3) |  | — |  | 11,184 |
|  | 1,029 |  | 13,807 |
(1) Awards were not vested (2) Awards were anti-dilutive (3) Shares were anti-dilutive for the three months ended September 30, 2011. The following table sets forth a reconciliation of the net income from continuing operations available to common shareholders and the net income from continuing operations for diluted earnings per share under the if-converted method:
|  | For the Three Months Ended September 30, |
|  | 2012 |  | 2011 |
|  | (Dollars in thousands) |
Net income from continuing operations available to common shareholders (as restated) |  | $ | 34,647 |  | $ | 5,622 |
Effect of dilutive securities: |  |  |  |  |
Interest on convertible debt, net of taxes |  | 2,130 |  | — |
Net income from continuing operations for diluted earnings per share (as restated) |  | $ | 36,777 |  | $ | 5,622 |
Additional Paid-In Capital: The change in additional paid-in capital during the three months ended September 30, 2012 was due to the following:
|  | (Dollars in thousands) |
Balance, June 30, 2012 |  | $ | 346,943 |
Stock-based compensation |  | 1,818 |
Vested stock option and stock appreciation right expirations |  | (1,126 | )
Taxes related to restricted stock |  | (105 | )
Net tax loss from stock-based compensation plans |  | (165 | )
Proceeds from exercise of stock options and stock appreciation rights |  | 45 |
Other |  | (2 | )
Balance, September 30, 2012 |  | $ | 347,408 |
Accumulated Other Comprehensive Income: The Company completed the sale of its investment in Provalliance during the three months ended September 30, 2012 and subsequently liquidated all foreign entities with Euro denominated operations. Amounts previously classified within accumulated other comprehensive income that were recognized in earnings were foreign currency translation rate gain adjustments of $43.4 million, as restated, a cumulative tax-effected net loss of $7.9 million associated with a cross-currency swap that was settled in fiscal year 2007 that hedged the Company’s European operations, and a $1.7 million net loss associated with cash repatriation from the Company’s European operations, which nets to $33.8 million, as restated.

X
- Details
Name: | rgs_ShareholdersEquityDisclosureAbstract
Namespace Prefix: | rgs_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Also includes disclosure of compensation-related costs for equity-based compensation which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details, and employee stock purchase plan details. + References No definition available. + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration